Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen C Hadler

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Vaccine|August 17, 2013
Reprint of: Epidemiological serosurvey of Hepatitis B in China--declining HBV prevalence due to Hepatitis B vaccinationXiaofeng Liang, Shengli Bi, Weizhong Yang, et al.
The Journal of Infectious Diseases|May 28, 2009
Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in ChinaXiaofeng Liang, Shengli Bi, Weizhong Yang, et al.
MMWR. Morbidity and Mortality Weekly Report|March 4, 2021
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Janssen COVID-19 Vaccine - United States, February 2021Sara E Oliver, Julia W Gargano, Heather Scobie, et al.
MMWR. Morbidity and Mortality Weekly Report|November 10, 2021
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5-11 Years - United States, November 2021Kate R Woodworth, Danielle Moulia, Jennifer P Collins, et al.
MMWR. Morbidity and Mortality Weekly Report|April 29, 2021
Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021Jessica R MacNeil, John R Su, Karen R Broder, et al.
MMWR. Morbidity and Mortality Weekly Report|May 20, 2021
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12-15 Years - United States, May 2021Megan Wallace, Kate R Woodworth, Julia W Gargano, et al.
MMWR. Morbidity and Mortality Weekly Report|September 23, 2021
Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2021Kathleen Dooling, Julia W Gargano, Danielle Moulia, et al.
MMWR. Morbidity and Mortality Weekly Report|November 4, 2021
The Advisory Committee on Immunization Practices' Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines - United States, 2021Sarah Mbaeyi, Sara E Oliver, Jennifer P Collins, et al.
MMWR. Morbidity and Mortality Weekly Report|July 8, 2021
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021Julia W Gargano, Megan Wallace, Stephen C Hadler, et al.
MMWR. Morbidity and Mortality Weekly Report|January 20, 2022
Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices - United States, December 2021Sara E Oliver, Megan Wallace, Isaac See, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Vaccine|August 17, 2013
Reprint of: Epidemiological serosurvey of Hepatitis B in China--declining HBV prevalence due to Hepatitis B vaccinationXiaofeng Liang, Shengli Bi, Weizhong Yang, et al.
The Journal of Infectious Diseases|May 28, 2009
Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in ChinaXiaofeng Liang, Shengli Bi, Weizhong Yang, et al.
MMWR. Morbidity and Mortality Weekly Report|March 4, 2021
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Janssen COVID-19 Vaccine - United States, February 2021Sara E Oliver, Julia W Gargano, Heather Scobie, et al.
MMWR. Morbidity and Mortality Weekly Report|November 10, 2021
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5-11 Years - United States, November 2021Kate R Woodworth, Danielle Moulia, Jennifer P Collins, et al.
MMWR. Morbidity and Mortality Weekly Report|April 29, 2021
Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021Jessica R MacNeil, John R Su, Karen R Broder, et al.
MMWR. Morbidity and Mortality Weekly Report|May 20, 2021
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12-15 Years - United States, May 2021Megan Wallace, Kate R Woodworth, Julia W Gargano, et al.
MMWR. Morbidity and Mortality Weekly Report|September 23, 2021
Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, September 2021Kathleen Dooling, Julia W Gargano, Danielle Moulia, et al.
MMWR. Morbidity and Mortality Weekly Report|November 4, 2021
The Advisory Committee on Immunization Practices' Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines - United States, 2021Sarah Mbaeyi, Sara E Oliver, Jennifer P Collins, et al.
MMWR. Morbidity and Mortality Weekly Report|July 8, 2021
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021Julia W Gargano, Megan Wallace, Stephen C Hadler, et al.
MMWR. Morbidity and Mortality Weekly Report|January 20, 2022
Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices - United States, December 2021Sara E Oliver, Megan Wallace, Isaac See, et al.
Pageof 5